May 30, 2018
China Drug Administration approves Gilead’s chronic hepatitis C virus infection drug
Gilead Sciences has gotten the approval from the China Drug Administration (CDA) of Epclusa for the treatment of adults with…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
May 30, 2018
FDA expedites review of Novartis drug Promacta for first-line severe aplastic anemia
Novartis said Tuesday that the US Food and Drug Administration (FDA) has accepted the its supplemental New Drug Application (sNDA)…
May 30, 2018
Allergan recalls pregnancy prevention pills due to out of sequence capsules
Allergan is recalling one lot of Taytulla physicians sample pack, indicated for use by women to prevent pregnancy, because of…
May 30, 2018
AstraZeneca’s COPD drug failed to meet the primary endpoint
AstraZeneca and MedImmune, said that the trial Terranova, the second of two pivotal Phase III trials for Fasenra (benralizumab) in patients…
May 29, 2018
Akers withdraw its application for PIFA CHlamydia AKR.L
Akers Biosciences has decided to withdaw its initial 510(k) application for PIFA Chlamydia in order to re-evaluate its options with…
May 29, 2018
FDA accepts larotrectinib Bayer’s New Drug Application and grants priority review
The U.S. Food and Drug Administration (FDA) has accepted Bayer’s partner’s Loxo Oncology’s New Drug Application (NDA), and granted Priority…
May 29, 2018
Novartis reports significant improvement in symptom frequency and quality of life domains with Entresto
Novartis has gotten new evidence from the CHAMP-HF registry comparing Entresto patients to patients not taking Entresto, which showed that…
May 28, 2018
FDA warns about certain OTC teething products being risky for children
The U.S. Food and Drug Administration has issued a warning about the over-the-counter (OTC) teething products containing benzocaine pose a…
May 25, 2018
AstraZeneca’s Imfinzi improves overall survival in trial for cell lung cancer
AstraZeneca and MedImmune, its global biologics research and development arm, on Friday reported positive overall survival (OS) results for the…
May 25, 2018
FDA OK’s AkaRx’s liver drug
The U.S. Food and Drug Administration has approved AkaRx’s Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with…